Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause | MicrobiomeTrials← Back to trialsNCT07118891
Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-06-23Est. Completion: 2027-02
Enrollment target: 136 participants Locations- CaRe Clinics, Calgary, Alberta, Canada
- CaRe Clinics, Red Deer, Alberta, Canada
- Mount Saint Joseph Hospital Clinical Trials Phase 1 Unit, Vancouver, British Columbia, Canada
- Centricity Research, Toronto, Ontario, Canada
- Centricity Research, Toronto, Ontario, Canada
- Alpha Recherche Clinique, Lévis, Quebec, Canada
- GCP Research, Montreal, Quebec, Canada
- Altasciences Company Inc., Mount Royal, Quebec, Canada
- Clinique RSF Inc., Québec, Quebec, Canada
- Diex Recherche Québec, Québec, Quebec, Canada
- Diex Recherche Sherbrooke, Sherbrooke, Quebec, Canada
- Diex Recherche Trois-Rivières, Trois-Rivières, Quebec, Canada
- Diex Recherche Victoriaville, Victoriaville, Quebec, Canada
Other microbiome trials you might be interested in
Vasomotor Symptoms (VMS) Associated With Menopause
This is an observational study to learn more about vasomotor symptoms (VSM) burden and treatment patterns in menopausal …
Whippany, United StatesCompleted Aug 28, 2025
Vasomotor Symptoms (VMS) Associated With Menopause
Menopause is a natural stage in a woman's life happening between ages 45 and 55. It is often associated with disruptive …
Whippany, United StatesEst. completion Nov 2, 2029